Primary Site >> Liver Cancer
Gene >> REG1A
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: A novel gene (HIP) activated in human primary liver cancer. PMID: 1325291 |
Ref: Structural organization and chromosomal localization of a human gene (HIP/PAP) encoding a C-type lectin overexpressed in primary liver cancer. PMID: 8076648 |
Ref: Molecular cloning and expression of peptide 23, a growth hormone-releasing hormone-inducible pituitary protein. PMID: 7895644 |
Ref: Crystallization and preliminary crystallographic study of HIP/PAP, a human C-lectin overexpressed in primary liver cancers. PMID: 10417404 |
Ref: Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis. PMID: 15814635 |
Ref: RegII is a beta-cell protein and autoantigen in diabetes of NOD mice. PMID: 17192462 |
Ref: Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. PMID: 21684822 |
Ref: Tissue-specific transplantation antigen P35B (TSTA3) immune response-mediated metabolism coupling cell cycle to postreplication repair network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by biocomputation. PMID: 22528125 |
Ref: Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era. PMID: 29184682 |
Ref: Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation. PMID: 29330507 Ref: Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis. PMID: 30144256 |